WestEnd Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303 | Hold |
2
| – | – | ﹤0.01% | 327 |
|
|
2025
Q1 | $301 | Buy |
2
+1
| +100% | +$151 | ﹤0.01% | 315 |
|
|
2024
Q4 | $185 | Hold |
1
| – | – | ﹤0.01% | 265 |
|
|
2024
Q3 | $197 | Hold |
1
| – | – | ﹤0.01% | 291 |
|
|
2024
Q2 | $207 | Hold |
1
| – | – | ﹤0.01% | 260 |
|
|
2024
Q1 | $271 | Hold |
1
| – | – | ﹤0.01% | 220 |
|
|
2023
Q4 | $236 | Hold |
1
| – | – | ﹤0.01% | 220 |
|
|
2023
Q3 | $196 | Buy |
+1
| New | +$196 | ﹤0.01% | 234 |
|
|
2023
Q2 | – | Hold |
0
| – | -$202 | – | 97 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$218 | – | 233 |
|
|
2022
Q4 | $218 | Hold |
1
| – | – | ﹤0.01% | 220 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 177 |
|
|
2022
Q2 | $213 | Buy |
+1
| New | +$213 | ﹤0.01% | 211 |
|